RETRACTION article

Front. Cell. Neurosci., 21 December 2023

Sec. Cellular Neuropathology

Volume 17 - 2023 | https://doi.org/10.3389/fncel.2023.1355800

Retraction: 1, 25-D3 protects from cerebral ischemia by maintaining BBB permeability via PPAR-γ activation

  • Frontiers Media SA, Lausanne, Switzerland

The journal retracts the 17th December 2018 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.

This retraction was approved by the Chief Editors of Frontiers in Cellular Neuroscience and the Chief Executive Editor of Frontiers. The authors did not agree to this retraction.

Summary

Keywords

blood-brain barrier permeability, 1, 25-dihydroxyvitamin D3, Middle cerebral artery occlusion/reperfusion, peroxisome proliferator-activated receptor gamma, Nuclear factor kappa-B, Inflammation, BDNF

Citation

Frontiers Editorial Office (2023) Retraction: 1, 25-D3 protects from cerebral ischemia by maintaining BBB permeability via PPAR-γ activation. Front. Cell. Neurosci. 17:1355800. doi: 10.3389/fncel.2023.1355800

Received

14 December 2023

Accepted

15 December 2023

Published

21 December 2023

Approved by

Dirk M. Hermann, University of Duisburg-Essen, Germany

Volume

17 - 2023

Updates

Copyright

*Correspondence: Frontiers Editorial Office

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics